Cargando…
Rapid and robust phylotyping of spa t003, a dominant MRSA clone in Luxembourg and other European countries
BACKGROUND: spa typing is a common genotyping tool for methicillin-resistant Staphylococcus aureus (MRSA) in Europe. Given the high prevalence of dominant clones, spa-typing is proving to be limited in its ability to distinguish outbreak isolates from background isolates. New molecular tools need to...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733620/ https://www.ncbi.nlm.nih.gov/pubmed/23879266 http://dx.doi.org/10.1186/1471-2334-13-339 |
_version_ | 1782279372862914560 |
---|---|
author | Engelthaler, David M Kelley, Erin Driebe, Elizabeth M Bowers, Jolene Eberhard, Carl F Trujillo, Jesse Decruyenaere, Frederic Schupp, James M Mossong, Joel Keim, Paul Even, Jos |
author_facet | Engelthaler, David M Kelley, Erin Driebe, Elizabeth M Bowers, Jolene Eberhard, Carl F Trujillo, Jesse Decruyenaere, Frederic Schupp, James M Mossong, Joel Keim, Paul Even, Jos |
author_sort | Engelthaler, David M |
collection | PubMed |
description | BACKGROUND: spa typing is a common genotyping tool for methicillin-resistant Staphylococcus aureus (MRSA) in Europe. Given the high prevalence of dominant clones, spa-typing is proving to be limited in its ability to distinguish outbreak isolates from background isolates. New molecular tools need to be employed to improve subtyping of dominant local MRSA strains (e.g., spa type t003). METHODS: Phylogenetically critical, or canonical, SNPs (can-SNPs) were identified as subtyping targets through sequence analysis of 40 MRSA whole genomes from Luxembourg. Real-time PCR assays were designed around target SNPs and validated using a repository of 240 previously sub-typed and epidemiologically characterized Luxembourg MRSA isolates, including 153 community and hospital isolates, 69 isolates from long term care (LTC) facilities, and 21 prospectively analyzed MRSA isolates. Selected isolates were also analyzed by whole genome SNP typing (WGST) for comparison to the SNP assays and other subtyping techniques. RESULTS: Fourteen real-time PCR assays were developed and validated, including two assays to determine presence of spa t003 or t008. The other twelve assays successfully provided a high degree of resolution within the t003 subtype. WGST analysis of the LTC facility isolates provided greater resolution than other subtyping tools, identifying clusters indicative of ongoing transmission within LTC facilities. CONCLUSIONS: canSNP-based PCR assays are useful for local level MRSA phylotyping, especially in the presence of one or more dominant clones. The assays designed here can be easily adapted for investigating t003 MRSA strains in other regions in Western Europe. WGST provides substantially better resolution than other typing methods. |
format | Online Article Text |
id | pubmed-3733620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37336202013-08-06 Rapid and robust phylotyping of spa t003, a dominant MRSA clone in Luxembourg and other European countries Engelthaler, David M Kelley, Erin Driebe, Elizabeth M Bowers, Jolene Eberhard, Carl F Trujillo, Jesse Decruyenaere, Frederic Schupp, James M Mossong, Joel Keim, Paul Even, Jos BMC Infect Dis Research Article BACKGROUND: spa typing is a common genotyping tool for methicillin-resistant Staphylococcus aureus (MRSA) in Europe. Given the high prevalence of dominant clones, spa-typing is proving to be limited in its ability to distinguish outbreak isolates from background isolates. New molecular tools need to be employed to improve subtyping of dominant local MRSA strains (e.g., spa type t003). METHODS: Phylogenetically critical, or canonical, SNPs (can-SNPs) were identified as subtyping targets through sequence analysis of 40 MRSA whole genomes from Luxembourg. Real-time PCR assays were designed around target SNPs and validated using a repository of 240 previously sub-typed and epidemiologically characterized Luxembourg MRSA isolates, including 153 community and hospital isolates, 69 isolates from long term care (LTC) facilities, and 21 prospectively analyzed MRSA isolates. Selected isolates were also analyzed by whole genome SNP typing (WGST) for comparison to the SNP assays and other subtyping techniques. RESULTS: Fourteen real-time PCR assays were developed and validated, including two assays to determine presence of spa t003 or t008. The other twelve assays successfully provided a high degree of resolution within the t003 subtype. WGST analysis of the LTC facility isolates provided greater resolution than other subtyping tools, identifying clusters indicative of ongoing transmission within LTC facilities. CONCLUSIONS: canSNP-based PCR assays are useful for local level MRSA phylotyping, especially in the presence of one or more dominant clones. The assays designed here can be easily adapted for investigating t003 MRSA strains in other regions in Western Europe. WGST provides substantially better resolution than other typing methods. BioMed Central 2013-07-23 /pmc/articles/PMC3733620/ /pubmed/23879266 http://dx.doi.org/10.1186/1471-2334-13-339 Text en Copyright © 2013 Engelthaler et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Engelthaler, David M Kelley, Erin Driebe, Elizabeth M Bowers, Jolene Eberhard, Carl F Trujillo, Jesse Decruyenaere, Frederic Schupp, James M Mossong, Joel Keim, Paul Even, Jos Rapid and robust phylotyping of spa t003, a dominant MRSA clone in Luxembourg and other European countries |
title | Rapid and robust phylotyping of spa t003, a dominant MRSA clone in Luxembourg and other European countries |
title_full | Rapid and robust phylotyping of spa t003, a dominant MRSA clone in Luxembourg and other European countries |
title_fullStr | Rapid and robust phylotyping of spa t003, a dominant MRSA clone in Luxembourg and other European countries |
title_full_unstemmed | Rapid and robust phylotyping of spa t003, a dominant MRSA clone in Luxembourg and other European countries |
title_short | Rapid and robust phylotyping of spa t003, a dominant MRSA clone in Luxembourg and other European countries |
title_sort | rapid and robust phylotyping of spa t003, a dominant mrsa clone in luxembourg and other european countries |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733620/ https://www.ncbi.nlm.nih.gov/pubmed/23879266 http://dx.doi.org/10.1186/1471-2334-13-339 |
work_keys_str_mv | AT engelthalerdavidm rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT kelleyerin rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT driebeelizabethm rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT bowersjolene rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT eberhardcarlf rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT trujillojesse rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT decruyenaerefrederic rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT schuppjamesm rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT mossongjoel rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT keimpaul rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries AT evenjos rapidandrobustphylotypingofspat003adominantmrsacloneinluxembourgandothereuropeancountries |